RPG Investment Advisory’s iShares Biotechnology ETF IBB Stock Holding History

RPG Investment Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,010	Closed	-$257K	–	91
2025 Q1	$257K	Buy	+2,010	New	+$273K	0.02%	89
2017 Q4	–	Sell	-6,411	Closed	-$713K	–	499
2017 Q3	$713K	Sell	6,411 -690	-10%	-$73.7K	0.18%	84
2017 Q2	$734K	Sell	7,101 -180	-2%	-$17.7K	0.2%	83
2017 Q1	$711K	Sell	7,281 -1,014	-12%	-$97.1K	0.21%	83
2016 Q4	$733K	Sell	8,295 -390	-4%	-$35.5K	0.25%	74
2016 Q3	$837K	Buy	8,685 +1,140	+15%	+$108K	0.26%	78
2016 Q2	$647K	Buy	7,545 +4,455	+144%	+$400K	0.17%	89
2016 Q1	$268K	Buy	3,090 +150	+5%	+$13.4K	0.1%	92
2015 Q4	$331K	Buy	+2,940	New	+$319K	0.12%	84

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

RPG Investment Advisory's IBB Position: Q2 2025 in Review

RPG Investment Advisory sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 2,010 shares — an estimated $257K sold.

RPG Investment Advisory first reported a position in IBB in Q4 2015 and held it in 9 quarters. The position peaked at $837K in Q3 2016. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

RPG Investment Advisory reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
RPG Investment Advisory sold 2,010 iShares Biotechnology ETF shares in Q2 2025, an estimated $257K.
RPG Investment Advisory first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 9 quarters.
RPG Investment Advisory's iShares Biotechnology ETF position peaked at $837K in Q3 2016.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on RPG Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.